MEDINET Co., Ltd. (2370)

Market cap
¥7.9B
P/E ratio
-5.5x
Medinet develops cell processing and regenerative medicine products for hospitals and pharmaceutical companies, offering manufacturing services and facility operations.
Period EndTotal liabilities (Million JPY)YoY (%)
Sep 30, 2025476-6.43%
Sep 30, 2024509-13.71%
Sep 30, 2023590+4.25%
Sep 30, 2022566+19.20%
Sep 30, 2021475+7.21%
Sep 30, 2020443-10.28%
Sep 30, 2019494-20.89%
Sep 30, 2018624-20.56%
Sep 30, 2017786-54.21%
Sep 30, 20161,715-0.50%
Sep 30, 20151,724+17.44%
Sep 30, 20141,468
AI Chat